Castration Resistant Prostate Cancer Treatment Market
1 Study Coverage
1.1 Castration Resistant Prostate Cancer Treatment Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million) Introduction
1.2 Global Castration Resistant Prostate Cancer Treatment Outlook 2017 VS 2022 VS 2028
1.2.1 Global Castration Resistant Prostate Cancer Treatment Market Size for the Year 2017-2028
1.2.2 Global Castration Resistant Prostate Cancer Treatment Market Size for the Year 2017-2028
1.3 Castration Resistant Prostate Cancer Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Castration Resistant Prostate Cancer Treatment in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Castration Resistant Prostate Cancer Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Castration Resistant Prostate Cancer Treatment Market Dynamics
1.4.1 Castration Resistant Prostate Cancer Treatment Industry Trends
1.4.2 Castration Resistant Prostate Cancer Treatment Market Drivers
1.4.3 Castration Resistant Prostate Cancer Treatment Market Challenges
1.4.4 Castration Resistant Prostate Cancer Treatment Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Castration Resistant Prostate Cancer Treatment by Type
2.1 Castration Resistant Prostate Cancer Treatment Market Segment by Type
2.1.1 Hormonal Therapy
2.1.2 Adding An Anti-Androgen
2.1.3 Stopping An Anti-Androgen
2.1.4 Estrogens
2.1.5 Chemotherapy
2.1.6 Radiation Therapy
2.1.7 Others
2.2 Global Castration Resistant Prostate Cancer Treatment Market Size by Type (2017, 2022 & 2028)
2.3 Global Castration Resistant Prostate Cancer Treatment Market Size by Type (2017-2028)
2.4 United States Castration Resistant Prostate Cancer Treatment Market Size by Type (2017, 2022 & 2028)
2.5 United States Castration Resistant Prostate Cancer Treatment Market Size by Type (2017-2028)
3 Castration Resistant Prostate Cancer Treatment by Application
3.1 Castration Resistant Prostate Cancer Treatment Market Segment by Application
3.1.1 Hospital
3.1.2 Ambulatory Surgical Centers
3.2 Global Castration Resistant Prostate Cancer Treatment Market Size by Application (2017, 2022 & 2028)
3.3 Global Castration Resistant Prostate Cancer Treatment Market Size by Application (2017-2028)
3.4 United States Castration Resistant Prostate Cancer Treatment Market Size by Application (2017, 2022 & 2028)
3.5 United States Castration Resistant Prostate Cancer Treatment Market Size by Application (2017-2028)
4 Global Castration Resistant Prostate Cancer Treatment Competitor Landscape by Company
4.1 Global Castration Resistant Prostate Cancer Treatment Market Size by Company
4.1.1 Top Global Castration Resistant Prostate Cancer Treatment Companies Ranked by Revenue (2021)
4.1.2 Global Castration Resistant Prostate Cancer Treatment Revenue by Player (2017-2022)
4.2 Global Castration Resistant Prostate Cancer Treatment Concentration Ratio (CR)
4.2.1 Castration Resistant Prostate Cancer Treatment Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Castration Resistant Prostate Cancer Treatment in 2021
4.2.3 Global Castration Resistant Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Castration Resistant Prostate Cancer Treatment Headquarters, Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million) Type
4.3.1 Global Castration Resistant Prostate Cancer Treatment Headquarters and Area Served
4.3.2 Global Castration Resistant Prostate Cancer Treatment Companies Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Castration Resistant Prostate Cancer Treatment Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Castration Resistant Prostate Cancer Treatment Market Size by Company
4.5.1 Top Castration Resistant Prostate Cancer Treatment Players in United States, Ranked by Revenue (2021)
4.5.2 United States Castration Resistant Prostate Cancer Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Castration Resistant Prostate Cancer Treatment Market Size by Region
5.1 Global Castration Resistant Prostate Cancer Treatment Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Castration Resistant Prostate Cancer Treatment Market Size by Region (2017-2028)
5.2.1 Global Castration Resistant Prostate Cancer Treatment Market Size by Region: 2017-2022
5.2.2 Global Castration Resistant Prostate Cancer Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Castration Resistant Prostate Cancer Treatment Market Size YoY Growth 2017-2028
6.1.2 North America Castration Resistant Prostate Cancer Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Castration Resistant Prostate Cancer Treatment Market Size YoY Growth 2017-2028
6.3.2 Europe Castration Resistant Prostate Cancer Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Castration Resistant Prostate Cancer Treatment Market Size YoY Growth 2017-2028
6.4.2 Latin America Castration Resistant Prostate Cancer Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Castration Resistant Prostate Cancer Treatment Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Castration Resistant Prostate Cancer Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Active Biotech
7.1.1 Active Biotech Company Details
7.1.2 Active Biotech Business Overview
7.1.3 Active Biotech Castration Resistant Prostate Cancer Treatment Introduction
7.1.4 Active Biotech Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
7.1.5 Active Biotech Recent Development
7.2 Diagnocure
7.2.1 Diagnocure Company Details
7.2.2 Diagnocure Business Overview
7.2.3 Diagnocure Castration Resistant Prostate Cancer Treatment Introduction
7.2.4 Diagnocure Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
7.2.5 Diagnocure Recent Development
7.3 Glaxosmithkline
7.3.1 Glaxosmithkline Company Details
7.3.2 Glaxosmithkline Business Overview
7.3.3 Glaxosmithkline Castration Resistant Prostate Cancer Treatment Introduction
7.3.4 Glaxosmithkline Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
7.3.5 Glaxosmithkline Recent Development
7.4 Northwest Biotherapeutics
7.4.1 Northwest Biotherapeutics Company Details
7.4.2 Northwest Biotherapeutics Business Overview
7.4.3 Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Introduction
7.4.4 Northwest Biotherapeutics Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
7.4.5 Northwest Biotherapeutics Recent Development
7.5 Millennium Pharmaceuticals
7.5.1 Millennium Pharmaceuticals Company Details
7.5.2 Millennium Pharmaceuticals Business Overview
7.5.3 Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction
7.5.4 Millennium Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
7.5.5 Millennium Pharmaceuticals Recent Development
7.6 Hologic
7.6.1 Hologic Company Details
7.6.2 Hologic Business Overview
7.6.3 Hologic Castration Resistant Prostate Cancer Treatment Introduction
7.6.4 Hologic Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
7.6.5 Hologic Recent Development
7.7 Spectrum Pharmaceuticals
7.7.1 Spectrum Pharmaceuticals Company Details
7.7.2 Spectrum Pharmaceuticals Business Overview
7.7.3 Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction
7.7.4 Spectrum Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
7.7.5 Spectrum Pharmaceuticals Recent Development
7.8 Abbott Laboratories
7.8.1 Abbott Laboratories Company Details
7.8.2 Abbott Laboratories Business Overview
7.8.3 Abbott Laboratories Castration Resistant Prostate Cancer Treatment Introduction
7.8.4 Abbott Laboratories Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
7.8.5 Abbott Laboratories Recent Development
7.9 Bayer Healthcare Pharmaceuticals
7.9.1 Bayer Healthcare Pharmaceuticals Company Details
7.9.2 Bayer Healthcare Pharmaceuticals Business Overview
7.9.3 Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction
7.9.4 Bayer Healthcare Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
7.9.5 Bayer Healthcare Pharmaceuticals Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Castration Resistant Prostate Cancer Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Castration Resistant Prostate Cancer Treatment Market Trends
Table 3. Castration Resistant Prostate Cancer Treatment Market Drivers
Table 4. Castration Resistant Prostate Cancer Treatment Market Challenges
Table 5. Castration Resistant Prostate Cancer Treatment Market Restraints
Table 6. Global Castration Resistant Prostate Cancer Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Castration Resistant Prostate Cancer Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Castration Resistant Prostate Cancer Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Castration Resistant Prostate Cancer Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Castration Resistant Prostate Cancer Treatment Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Castration Resistant Prostate Cancer Treatment Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Castration Resistant Prostate Cancer Treatment Revenue Share by Player, 2017-2022
Table 13. Global Castration Resistant Prostate Cancer Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Castration Resistant Prostate Cancer Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Castration Resistant Prostate Cancer Treatment as of 2021)
Table 15. Top Players of Castration Resistant Prostate Cancer Treatment in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Castration Resistant Prostate Cancer Treatment Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Castration Resistant Prostate Cancer Treatment Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Castration Resistant Prostate Cancer Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Castration Resistant Prostate Cancer Treatment Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Castration Resistant Prostate Cancer Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Castration Resistant Prostate Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Castration Resistant Prostate Cancer Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Castration Resistant Prostate Cancer Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Castration Resistant Prostate Cancer Treatment Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Castration Resistant Prostate Cancer Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Castration Resistant Prostate Cancer Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Castration Resistant Prostate Cancer Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Active Biotech Company Details
Table 31. Active Biotech Business Overview
Table 32. Active Biotech Castration Resistant Prostate Cancer Treatment Product
Table 33. Active Biotech Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
Table 34. Active Biotech Recent Development
Table 35. Diagnocure Company Details
Table 36. Diagnocure Business Overview
Table 37. Diagnocure Castration Resistant Prostate Cancer Treatment Product
Table 38. Diagnocure Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
Table 39. Diagnocure Recent Development
Table 40. Glaxosmithkline Company Details
Table 41. Glaxosmithkline Business Overview
Table 42. Glaxosmithkline Castration Resistant Prostate Cancer Treatment Product
Table 43. Glaxosmithkline Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
Table 44. Glaxosmithkline Recent Development
Table 45. Northwest Biotherapeutics Company Details
Table 46. Northwest Biotherapeutics Business Overview
Table 47. Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Product
Table 48. Northwest Biotherapeutics Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
Table 49. Northwest Biotherapeutics Recent Development
Table 50. Millennium Pharmaceuticals Company Details
Table 51. Millennium Pharmaceuticals Business Overview
Table 52. Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product
Table 53. Millennium Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
Table 54. Millennium Pharmaceuticals Recent Development
Table 55. Hologic Company Details
Table 56. Hologic Business Overview
Table 57. Hologic Castration Resistant Prostate Cancer Treatment Product
Table 58. Hologic Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
Table 59. Hologic Recent Development
Table 60. Spectrum Pharmaceuticals Company Details
Table 61. Spectrum Pharmaceuticals Business Overview
Table 62. Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product
Table 63. Spectrum Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
Table 64. Spectrum Pharmaceuticals Recent Development
Table 65. Abbott Laboratories Company Details
Table 66. Abbott Laboratories Business Overview
Table 67. Abbott Laboratories Castration Resistant Prostate Cancer Treatment Product
Table 68. Abbott Laboratories Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
Table 69. Abbott Laboratories Recent Development
Table 70. Bayer Healthcare Pharmaceuticals Company Details
Table 71. Bayer Healthcare Pharmaceuticals Business Overview
Table 72. Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product
Table 73. Bayer Healthcare Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
Table 74. Bayer Healthcare Pharmaceuticals Recent Development
Table 75. Research Programs/Design for This Report
Table 76. Key Data Information from Secondary Sources
Table 77. Key Data Information from Primary Sources
List of Figures
Figure 1. Castration Resistant Prostate Cancer Treatment Product Picture
Figure 2. Global Castration Resistant Prostate Cancer Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Castration Resistant Prostate Cancer Treatment Market Size 2017-2028 (US$ Million)
Figure 4. United States Castration Resistant Prostate Cancer Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Castration Resistant Prostate Cancer Treatment Market Size 2017-2028 (US$ Million)
Figure 6. United States Castration Resistant Prostate Cancer Treatment Market Share in Global 2017-2028
Figure 7. Castration Resistant Prostate Cancer Treatment Report Years Considered
Figure 8. Product Picture of Hormonal Therapy
Figure 9. Product Picture of Adding An Anti-Androgen
Figure 10. Product Picture of Stopping An Anti-Androgen
Figure 11. Product Picture of Estrogens
Figure 12. Product Picture of Chemotherapy
Figure 13. Product Picture of Radiation Therapy
Figure 14. Product Picture of Others
Figure 15. Global Castration Resistant Prostate Cancer Treatment Market Share by Type in 2022 & 2028
Figure 16. Global Castration Resistant Prostate Cancer Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 17. Global Castration Resistant Prostate Cancer Treatment Market Share by Type (2017-2028)
Figure 18. United States Castration Resistant Prostate Cancer Treatment Market Share by Type in 2022 & 2028
Figure 19. United States Castration Resistant Prostate Cancer Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 20. United States Castration Resistant Prostate Cancer Treatment Market Share by Type (2017-2028)
Figure 21. Product Picture of Hospital
Figure 22. Product Picture of Ambulatory Surgical Centers
Figure 23. Global Castration Resistant Prostate Cancer Treatment Market Share by Application in 2022 & 2028
Figure 24. Global Castration Resistant Prostate Cancer Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 25. Global Castration Resistant Prostate Cancer Treatment Market Share by Application (2017-2028)
Figure 26. United States Castration Resistant Prostate Cancer Treatment Market Share by Application in 2022 & 2028
Figure 27. United States Castration Resistant Prostate Cancer Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 28. United States Castration Resistant Prostate Cancer Treatment Market Share by Application (2017-2028)
Figure 29. North America Castration Resistant Prostate Cancer Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 30. U.S. Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Canada Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Europe Castration Resistant Prostate Cancer Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 33. Germany Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. France Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. U.K. Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Italy Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Russia Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 39. China Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Japan Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. South Korea Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. India Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Australia Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Taiwan Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Indonesia Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Thailand Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Malaysia Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Philippines Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Latin America Castration Resistant Prostate Cancer Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Mexico Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Brazil Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Argentina Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 54. Turkey Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. U.A.E Castration Resistant Prostate Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 57. Active Biotech Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
Figure 58. Diagnocure Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
Figure 59. Glaxosmithkline Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
Figure 60. Northwest Biotherapeutics Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
Figure 61. Millennium Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
Figure 62. Hologic Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
Figure 63. Spectrum Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
Figure 64. Abbott Laboratories Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
Figure 65. Bayer Healthcare Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Industry Market Size
